Immune cells in bronchoalveolar lavage in peripheral lung cancer - Analysis of 140 cases

Respiration

Volumn 70, Issue 1, 2003, Pages 43-48

  Domagała Kulawik, Joanna ^a   Guzman, Josune ^b   Costabel, Ulrich ^c  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c RUHRLANDKLINIK   (Germany)

Author keywords

Bronchoalveolar lavage; Eosinophils; Immunology; Lung cancer; Lymphocyte subsets

Indexed keywords

EPITHELIAL MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPEROXIDASE STAINING; LUNG CANCER; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING; T LYMPHOCYTE; TUMOR CELL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRONCHOALVEOLAR LAVAGE FLUID; CA-15-3 ANTIGEN; CASE-CONTROL STUDIES; CD4-CD8 RATIO; EOSINOPHILS; FEMALE; HLA-DR ANTIGENS; HUMANS; LUNG NEOPLASMS; LYMPHOCYTES; MACROPHAGES; MALE; MAST CELLS; MIDDLE AGED; NEUTROPHILS; REFERENCE VALUES; RETROSPECTIVE STUDIES; SMOKING; T-LYMPHOCYTES;

EID: 0037285982     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068414     Document Type: Article

References (37)

1. Kurnick JT, Kradin RL, Blumberg R, Schneeberger EE, Boyle LA: Functional characterization of T lymphocytes propagated from human lung carcinomas. Clin Immunol Immunopathol 1986;38:367-380.
2. Olsen GN, Gangemi JD: Bronchoalveolar lavage and the immunology of primary lung cancer. Chest 1985;87:677-683.
3. Roussel E, Gingras MC, Grimm EA, Roth JA: High expression of adhesion molecules/activation markers with little interleukin-2, interferon gamma, and tumor necrosis factor beta gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma. Cancer Immunol Immunother 1995;41:1-9.
4. Yoshino I, Yano T, Murata M, Miyamoto M, Ishida T, Sugimachi K, Kimura G, Nomoto K: Phenotypes of lymphocytes infiltrating non-small-cell lung cancer tissues and its variation with histological types of cancer. Lung Cancer 1993;10:13-19.
5. Yoshino I, Yano T, Yoshikai Y, Murata M, Sugimachi K, Kimura G, Nomoto K: Oligoclonal T lymphocytes infiltrating human lung cancer tissues. Int J Cancer 1991;47:654-658.
6. Domagała-Kulawik J, Hoser G, Droszcz P, Kawiak J, Droszcz W, Chazan R: T cell subtypes in the bronchoalveolar lavage fluid and in the peripheral blood from patients with primary lung cancer. Diagn Cytopathol 2001;25:208-213.
7. Fracchia A, Pacetti M, Barberis M, Mura MA, Le Grazie C, Longhini E: Determination of T lymphocyte subpopulations in patients with lung cancer. A comparison between lung lavage and peripheral blood by monoclonal antibodies and flow cytometry. Respiration 1987;51:161-169.
8. Piazza G, Marchi E, Scaglione F, Montoli CC, Losi S, Scarpazza G: Lymphocyte subsets in bronchoalveolar lavage fluid and in circulating blood in epidermoid bronchogenic carcinoma. Respiration 1990;57:28-36.
9. Costabel U, Bross KJ, Reuter C, Ruehle KH, Matthys H: Alterations in immunoregulatory T-cell subsets in cigarette smokers. Chest 1986;90:39-44.
10. Poletti V, Romagna M, Allen KA, Gasponi A, Spiga L: Bronchoalveolar lavage in the diagnosis of disseminated lung tumors. Acta Cytol 1995;39:472-477.
11. Semenzato G, Poletti V: Bronchoalveolar lavage in lung cancer. Respiration 1992;59(suppl 1):44-46.
12. Ginns LC, Goldenheim PD, Miller LG, Burton RC, Gillick L, Colvin RB, Goldstein G, Kung PC, Hurwitz C, Kazemi H: T-lymphocyte subsets in smoking and lung cancer: Analysis of monoclonal antibodies and flow cytometry. Am Rev Respir Dis 1982;126:265-269.
13. Radhakrishna Pillai M, Balarm P, Padmanabhan TK, Abraham T, Hareendran NK, Nair K: Immunocompetence in lung cancer, relationship to extent of tumor burden and histologic type. Cancer 1989;42:1853-1858.
14. The BAL Co-operative Group Screening Committee: Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis 1990;141(suppl 5):S169-S202.
15. Le Fever A, Funahashi A: Lymphokine activated killer cell activity in lung cancer. Chest 1991;99:292-297.
16. Pitchenic AE, Gufee J, Stein-Streilein J: Lung natural killer and IL-2 activity in lung cancer. A pulmonary compartment of augmented natural killer activity occurs in patients with bronchogenic carcinoma. Am Rev Respir Dis 1987;136:1327-1332.
17. Linder J, Radio SJ, Robbins RA, Ghafouri M, Rennard SI: Bronchoalveolar lavage in the cytologic diagnosis of carcinoma of the lung. Acta Cytol 1987;31:796-801.
18. Ioachim HL, Dorsett BH, Paluch E: The immune response at the tumor site in lung carcinoma. Cancer 1976;38:2296-2309.
19. Roth MD, Golub SH: Inhibition of lymphokine-activated killer cell function by human alveolar macrophages. Cancer Res 1989;49:4690-4695.
20. Lemarie E, Carre P, Legrand MF, Lavandier M, Boissinot E, Renoux M, Renoux G: Alveolar macrophage dysfunction in malignant lung tumours. Thorax 1984;39:448-452.
21. Siziopikou KP, Ahn MC, Casey L, Silver M, Harris JE, Braun DP: Augmentation of impaired tumoricidal function in alveolar macrophages from lung cancer patients by cocultivation with allogeneic, but not autologous lymphocytes. Cancer Immunol Immunother 1997;45:29-36.
22. Striz I, Wang YM, Svarcova I, Trnka L, Sorg C, Costabel U: The phenotype of alveolar macrophages and its correlation with immune cells in bronchoalveolar lavage. Eur Respir J 1993;6:1287-1294.
23. Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D, Levitsky H: The central role of CD4(+) cells in the antitumor response. J Exp Med 1998;188:2357-2368.
24. Muller E, Kolb E: Local responses in primary and secondary human lung cancer. I. Patterns of cellular (eosinophils and macrophages) and extracellular (acid mucopolysacchride) reactions. Br J Cancer 1979;40:403-409.
25. Samoszuk M: Eosinophils and human cancer. Histol Histopathol 1997;12:807-812.
26. Wright P, Kelly P, Yazbeck J, Clancy L, Healy T: An association between sputum eosinophilia and carcinoma of the lung: A study of 549 patients. Ir J Med Sci 1994;163:492-493.
27. Allen JN, Davis WB, Pacht ER: Diagnostic significance of increased bronchoalveolar lavage eosinophila. Am Rev Respir Dis 1990;142:642-647.
28. Kuo SH, Cahng DB, Lee YC, Lee YT, Luh KT: Tumor-infiltrating lymphocytes in non-small cell lung cancer are activated T lymphocytes. Respirology 1998;3:55-59.
29. Moy PM, Holmes EC, Golub SH: Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors. Cancer Res 1985;45:57-60.
30. Swisher SG, Kiertscher SM, Golub SH, Holmes EC, Roth MD: Pulmonary macrophages suppress the proliferation and cytotoxicity of tumor-infiltrating lymphocytes. Am J Respir Cell Mol Biol 1993;8:486-492.
31. Fujisawa T, Yamaguchi Y: Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung. Cancer 1997;79:474-481.
32. Burger UL, Chang MP, Goedegebuure PS, Eberlein TJ, Adams-Hodgins S: Recruitment of host CD8+ T cells by tumor-infiltrating lymphocytes and recombinant interleukin-2 during adoptive immunotherapy of cancer. Surgery 1995;117:325-333.
33. Edwards RP, Kuykendall K, Crowley-Nowick P, Partridge EE, Shingleton HM, Mestecky J: T lymphocytes infiltrating advanced grades of cervical neoplasia. CD8-positive cells are recruited to invasion. Cancer 1995;76:1411-1415.
34. Hoser G, Kawiak J, Domagała-Kulawik J, Kopiński P, Droszcz W: Flow cytometric evaluation of lymphocyte subpopulations in the BALF of healthy smokers and nonsmokers. Folia Histochem Cytobiol 1999;37:25-30.
35. Wallace JM, Oishi JS, Barbers RG, Simmons MS, Tashkin DP: Lymphocytic subpopulation profiles in bronchoalveolar lavage fluid and peripheral blood from tobacco and marijuana smokers. Chest 1994;105:847-852.
36. Masuno T, Ikeda T, Yokota S, Komuta K, Ogura T, Kishimoto S: Immunoregulatory T-lymphocyte functions in patients with small cell lung cancer. Cancer Res 1986;46:4195-4199.
37. Riemann D, Wenzel K, Schulz T, Hofmann S, Neef H, Lautenschlager C, Langner J: Phenotypic analysis of T lymphocytes isolated from non-small-cell lung cancer. Int Arch Allergy Immunol 1997;114:38-45.